                         SEQUENCE LISTING

<110>  DANA-FARBER CANCER INSTITUTE, INC.
 
<120>  EZH2 INHIBITORS AND USES THEREOF

<130>  D0504.70080WO00

<140>  PCT/US2015/059622
<141>  2015-11-06

<150>  US 62/076,410
<151>  2014-11-06

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  1

His His His His His His 
1               5       


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  2

His His His His 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide

<400>  3

Leu Leu Leu Leu 
1               


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Polypeptide


<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa is epsilon protonated neutral histidine

<400>  4

Arg Phe Ala Asn Xaa Ser Val 
1               5           